Lv3
350 积分 2022-02-04 加入
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial
3个月前
已完结
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer
3个月前
已完结
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
4个月前
已完结
Management of patients with muscle-invasive bladder cancer with clinical evidence of pelvic lymph node metastases
4个月前
已完结
Bladder Cancer
4个月前
已关闭
Advances in bladder cancer biology and therapy
4个月前
已完结
History, Evolution, Milestones in Cancer Research and Treatment
4个月前
已完结
Enfortumab Vedotin and Pembrolizumab — A New Perspective on Urothelial Cancer
4个月前
已完结
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer
4个月前
已完结
Axial Spondyloarthritis: an overview of the disease
4个月前
已完结
皖公网安备34019202002308
